, Tracking Stock Market Picks
Enter Symbol:
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]

up 184.11 %

Amylin Pharmaceuticals, Inc. (AMLN) rated Accumulate with price target $14 by Global Hunter Securities

Posted on: Wednesday,  Dec 7, 2011  8:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Accumulate Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 12/07/2011, when the stock price was $10.89.
Since then, Amylin Pharmaceuticals, Inc. has gained 184.11% as of 08/06/2012's recent price of $30.94.
If you would have followed this Global Hunter Securities's recommendation on AMLN, you would have gained 184.11% of your investment in 243 days.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/7/2011 8:25 AM Buy
10.89 14.00
as of 12/30/2011
1 Week down  -0.52 %
1 Month up  4.49 %
3 Months   
1 YTD up  4.49 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy